A routine blood test could help predict who benefits most from CAR T-cell therapy

Measuring the lymphocytes—white blood cells that fight infection—in a patient’s blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to research from physicians at Fox Chase Cancer…

Continue Reading

News Source: medicalxpress.com